CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
- 16 February 1980
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 315 (8164), 327-329
- https://doi.org/10.1016/s0140-6736(80)90881-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionThe New England Journal of Medicine, 1979
- CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 1978
- IDIOPATHIC CARDIOMYOPATHY, AGE, AND SUPPRESSOR-CELL DYSFUNCTION AS RISK DETERMINANTS OF LYMPHOMA AFTER CARDIAC TRANSPLANTATIONThe Lancet, 1978
- One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationBlood, 1977
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976
- Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion.Proceedings of the National Academy of Sciences of the United States of America, 1976
- METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTSTransplantation, 1970